- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Continuous lavage with voriconazole CONTROLS progression in moderate and severe fungal keratitis
The study entitled "Continuous voriconazole lavage in managing moderate and severe fungal keratitis: a randomized controlled trial" by Gong et and the team has described the role of continuous lavage with voriconazole in controlling the progression of moderate and severe fungal keratitis. It does not cause damage to the corneal epithelium, stroma or conjunctiva.
This study is published in Graefe's Archive for Clinical and Experimental Ophthalmology.
It is already known that continuous lavage with antibiotics is proven to be SUCCESSFUL for managing resistant bacterial keratitis. This is because it increases the drug concentration in the cornea.
The main purpose of this study was to assess the effectiveness and safety of continuous lavage with 1% voriconazole (CL) for moderate and severe fungal keratitis.
The researchers randomized thirty-one patients receiving topical eye drops either alone (T) or combined with continuous 1% voriconazole lavage (CL-T) and measured the cure rate at three months as the primary outcomes.
The secondary outcomes were the 6-day efficacy, 3-day infiltration size and depth, hypopyon height, central corneal thickness (CCT), epithelial defect size, and subject feelings and clinical signs assessment scores.
At three months, the cure rate was comparable between the groups in patients with moderate fungal keratitis (66.7% vs 62.5%). Nearly four cases constituting 44.4 %, are the severe cases in the CL-T group healed successfully, while none in the T group; this difference was insignificant (small sample size).
After six days, the percentage of patients with "worsened" ulcers in the CL-T group was lower when compared to that of the T group, recorded as 0% vs 31%.
After three days, the infiltration size, infiltration depth, and hypopyon height in the CL-T group were smaller than in the T group. There was no difference between groups in CCT, epithelial defect size, subject feelings scores, or clinical signs scores.
They said, "In our research, we found that CL is an effective and safe adjuvant method for controlling the progression of moderate and severe fungal keratitis."
Further reading:
https://link.springer.com/article/10.1007/s00417-022-05969-z
BDS, MDS in Periodontics and Implantology
Dr. Aditi Yadav is a BDS, MDS in Periodontics and Implantology. She has a clinical experience of 5 years as a laser dental surgeon. She also has a Diploma in clinical research and pharmacovigilance and is a Certified data scientist. She is currently working as a content developer in e-health services. Dr. Yadav has a keen interest in Medical Journalism and is actively involved in Medical Research writing.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751